Skip to main content

Paul Colvin, Simon Britton, Consuelo Blosch, Dan Allison, Michael Torelli

PPD Names North America and Asia VPs in Expansion of Global Management Team
PPD, a global contract research organization based in Wilmington, NC, has named two new vice presidents in an expansion of its global management team:
  • Paul Colvin has been named senior vice president of clinical operations for North America, where he will oversee the company’s Phase II-IV operational unit. Colvin previously directed clinical operations and global patient enrollment optimization for Eli Lilly, capping 14 years of holding leadership positions with the pharma giant.
  • Simon Britton has been named vice president of clinical operations for Asia, a new senior management position. Britton spent the last seven years at GlaxoSmithKline where he most recently served as head of international clinical operations, managing the company's global clinical operations group across 25 countries.
With Britton's appointment, PPD has restructured its Phase II-IV operational units into four territories: North America; Latin America; Europe, the Middle East and Africa; and Asia.

VLST Names Clinical and Regulatory, Therapeutic Design Executives
VLST, a Seattle developer of therapeutics for autoimmune and inflammatory disorders, has named Consuelo Blosch as vice president of clinical and regulatory affairs and Dan Allison as senior director of therapeutic design.
Blosch previously served as administrative director of the Benaroya Research Institute at Virginia Mason’s clinical research program, and earlier held director-level positions at Immunex and NPS Pharmaceuticals. She received her MD from the University of Massachusetts Medical School.
From 1992 to 2007Allison worked as senior director of production development for Icos Corporation. Previously he worked at Genencor International. Allison received a PhD in genetics from the University of Washington and carried out postdoctoral studies in yeast cell biology at the Biozentrum in Basel, Switzerland, and in the biochemistry department at the University of Washington.

New York’s Empire State Development Corp. Names Mid-Hudson Regional Director
Michael Torelli has been named regional director for the mid-Hudson region of the Empire State Development Corporation, the economic development agency of New York state, effective Oct. 15. He succeeds Ronald Hicks, who left ESD earlier this year to become president and CEO of the Rockland Economic Development Corporation.
In his new position, Torelli will work with companies and local development agencies in the region, manage day-to-day operations for Empire State Development’s New Windsor and White Plains offices, and implement agency programs and projects.
Torelli previously served as director of business attraction for the public-private Orange County Partnership. From 1999 - 2002, he served as an account manager for ETC Data Services in Newburgh. Torelli was the inaugural recipient of the Orange County Rising Star Award in 2006, and is a founding member of the Alliance for Balanced Growth.  He earned a bachelor’s degree in business administration from the State University of New York-Brockport.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.